Maximilian Schmid

Maximilian Schmid currently serves as the Chief Medical Officer for Diagnostics at Danaher Corporation, where responsibilities include driving medical and scientific strategy for the diagnostics platform and enhancing medical excellence across disease areas. Prior to this role, Maximilian held consulting positions at Boston Consulting Group and operated Dr. Maximilian Schmid Consulting, providing strategic advisement on growth and product innovation in life sciences. As a Senior Advisor at ClearNote Health, Maximilian supported the launch of innovative cancer detection tests. Earlier experience includes serving as Chief Commercial Officer at CENTOGENE, successfully reversing revenue declines in the Diagnostics Business Unit, and as an Associate Professor at the Medical University of Vienna, holding advanced academic qualifications in the field.